Global Gene Therapy Medicine Market Outlook and Growth Opportunities 2025

Summary

According to APO Research, the global Gene Therapy Medicine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Gene Therapy Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Gene Therapy Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Gene Therapy Medicine market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Gene Therapy Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Gene Therapy Medicine market include Vical Inc., Spark Therapeutics, Sangamo, Dimension Therapeutics, Celladon, Bluebird Bio, Avalanche Bio and Advantagene, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Gene Therapy Medicine, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Gene Therapy Medicine, also provides the value of main regions and countries. Of the upcoming market potential for Gene Therapy Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Therapy Medicine revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Gene Therapy Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Gene Therapy Medicine company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Gene Therapy Medicine Segment by Company

Vical Inc.
Spark Therapeutics
Sangamo
Dimension Therapeutics
Celladon
Bluebird Bio
Avalanche Bio
Advantagene
Gene Therapy Medicine Segment by Type

Oral
Injection
Gene Therapy Medicine Segment by Application

Cancer
Infectious Disease
Monogenic
Cardiovascular Disease
Other
Gene Therapy Medicine Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Gene Therapy Medicine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Gene Therapy Medicine key companies, revenue, market share, and recent developments.
3. To split the Gene Therapy Medicine breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Gene Therapy Medicine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gene Therapy Medicine significant trends, drivers, influence factors in global and regions.
6. To analyze Gene Therapy Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Therapy Medicine industry.
Chapter 3: Detailed analysis of Gene Therapy Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Gene Therapy Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Gene Therapy Medicine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights. Show more